期刊簡介 | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | CNS Neuroscience & Therapeutics LetPub Score 7.4
50 ratings
Rate
Reputation 8.4 Influence 6.3 Speed 9.2 | ||||||||||||||||||||||||||||
期刊簡稱 | CNS NEUROSCI THER | ||||||||||||||||||||||||||||
ISSN | 1755-5930 | ||||||||||||||||||||||||||||
E-ISSN | 1755-5949 | ||||||||||||||||||||||||||||
h-index | 59 | ||||||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||||||
自引率 (2023-2024) | 4.20%自引率趨勢 | ||||||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||||||
官方網站 | https://onlinelibrary.wiley.com/journal/17555949 | ||||||||||||||||||||||||||||
在線稿件提交 | http://mc.manuscriptcentral.com/cnsdr | ||||||||||||||||||||||||||||
開放訪問 | Yes | ||||||||||||||||||||||||||||
出版商 | Wiley-Blackwell Publishing Ltd | ||||||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||||||
出版國/地區 | ENGLAND | ||||||||||||||||||||||||||||
發行頻率 | 四半期刊行 | ||||||||||||||||||||||||||||
創刊年 | 2008 | ||||||||||||||||||||||||||||
每年文章數 | 443每年文章數趨勢 | ||||||||||||||||||||||||||||
黃金OA百分比 | 77.78% | ||||||||||||||||||||||||||||
OA Related Info | APC: Yes( USD3410; GBP2590; EUR2920; ) APC waiver:Check Notes Other charges: No Keywords: neuroscience、neurology、central nervous system、pharmacology、degenerative diseases、pharmacokinetics Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | ||||||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1755-5930%5BISSN%5D | ||||||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 2 Month(s) | ||||||||||||||||||||||||||||
競爭力 * | 來自作者的數據: About 75% | ||||||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[CNS Neuroscience & Therapeutics] 的評論 | 撰寫評論 |
作者: 111112 領域: 医学 審稿時間: 12.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-09-29 22:07:30 評論於 The review process is too slow, hurry up for graduation.(0) 讚! | 111112 |
作者: TerryHo 領域: 医学 審稿時間: 3.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-04-02 22:57:35 評論於 Submitted October 4, 2023 Final revisions submitted December 15, 2023 Accepted March 25, 2024(0) 讚! | TerryHo |
作者: xwh123 領域: 医学 審稿時間: 1.0 month(s) 結果: 拒稿 撰寫評論 |
2023-06-03 09:31:57 評論於 Really rubbish, reviewed for a month, thought it was being reviewed, but it turns out it's still being edited over there, and they even said it would be quickly rejected...(1) 讚! | xwh123 |
作者: heyingkun 領域: 医学 審稿時間: 8.0 month(s) 結果: 修改後接受 撰寫評論 |
2023-03-05 12:19:40 評論於 Submitted October 27, 2022 Final revisions submitted January 27, 2023 Accepted February 14, 2023 Version of Record online February 27, 2023 Article made open access February 27, 2023(2) 讚! | heyingkun |
作者: 芒硝 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-26 09:53:07 評論於 Hello, may I ask if you will be submitting again in the old system? I also submitted my manuscript from the new system. I checked the "Author's Note" in the old system, which stated that if you submitted from the new system, you need to exit "ScholarOne Manuscripts" and return to the "Research Exchange" system. So, I'm not sure if I need to submit again.(0) 讚! | 芒硝 |
作者: zenithcloud 領域: 医学 審稿時間: 5.0 month(s) 結果: 拒稿 撰寫評論 |
2023-01-25 10:50:26 評論於 Not recommended at all, a trash magazine. It took 5 months for them to review the submission, and they only assigned one reviewer. The review comments were also very unprofessional.(0) 讚! | zenithcloud |
作者: hengzhang 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-10 23:33:08 評論於 I tell you, if you go into the old system again, you will find a column called "Author". On the left side, there is a section called "Submitted Manuscripts" where you can find the manuscripts you have submitted. Follow the steps there to submit and you will receive a manuscript number and an email.(0) 讚! | hengzhang |
作者: 我爱开心 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-08 21:53:16 評論於 It has been 2 days since I submitted with the new system, but it still shows "submitted" and I haven't received the Manuscript ID. Is this normal?(0) 讚! | 我爱开心 |
作者: 火星人科学家 領域: 医学 審稿時間: 1.0 month(s) 結果: 拒稿 撰寫評論 |
2019-08-21 09:53:40 評論於 It was stated on the submission site that "First review returned 7 working days from online submission". It was rejected in a week after submission and it doesn’t waste the time. (0) 讚! | 火星人科学家 |
作者: promoter 領域: 医药科学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2017-05-17 18:06:44 評論於 I don’t know what the IF will be this year, I hope to keep it at 4 points or more(0) 讚! | promoter |
作者: xxyuluo@126.com 領域: 生命科学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2015-11-24 14:52:40 評論於 Review speed at this journal is very efficient. After submitting the manuscript, I received the confirmation email from the AE almost immediately. The review was finished within 3 weeks and I revised and resubmitted my article within 4 weeks. I appreciate the journal’s highly efficient work attitude. In addition, the review does not charge, but official publication requires a $1000 US dollars page fee. (0) 讚! | xxyuluo@126.com |
作者: Anonymous 領域: 生命科学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2015-04-27 11:04:50 評論於 journal has risen, and the quality of the article is much higher than before.After all, it is a journal that Chinese people take over. I hope that the journal will be better and better, and at the same time strictly control the quality of the article and produce international-level journals.Don't sacrifice the quality of the article for the cost of the page.(0) 讚! | Anonymous |
作者: eagle 領域: 医药科学 審稿時間: 1.0 month(s) 結果: 直接被接受 撰寫評論 |
2014-11-18 18:07:07 評論於 Is it a few districts under the Chinese Academy of Sciences?(1) 讚! | eagle |
作者: 匿名 領域: 審稿時間: 0.0 month(s) 結果: 撰寫評論 |
2013-06-21 14:02:00 評論於 was edited by Su Dingfeng, professor of pharmacology at the Second Military Medical University. The deputy editors are Wang Yongjun and Hu Gang.(2) 讚! | 匿名 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us